Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selma Ugurel

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2008
Skin toxicity of anti-cancer therapyJens Ulrich, Jörg T Hartmann, Wolfgang Dörr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 2019
[Merkel cell carcinoma]Christina Drusio, Jürgen C Becker, Dirk Schadendorf, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2004
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?Selma Ugurel, Monika Lindemann, Dirk Schadendorf, et al.
Current Opinion in Oncology|January 22, 2013
New developments in biomarkers for melanomaKlaus G Griewank, Selma Ugurel, Dirk Schadendorf, et al.
American Journal of Clinical Dermatology|April 22, 2024
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic UpdatesJürgen C Becker, Andreas Stang, David Schrama, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Merkel cell carcinoma immunotherapy: key questions in the era of immune checkpoint blockadeJürgen C Becker, Georg Lodde, Maximilian Haist, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 28, 2019
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Imatinib in melanoma: a selective treatment option based on KIT mutation status?Jürgen C Becker, Eva B Bröcker, Dirk Schadendorf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 15, 2005
[90-year-old male with a hyperkeratotic lichenoid skin eruption]Ute Bauer, Selma Ugurel, Jochen Utikal, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 25, 2011
Regression of paclitaxel-induced maculopathy with oral acetazolamideKerstin Maria Meyer, Thomas Klink, Selma Ugurel, et al.
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2008
Skin toxicity of anti-cancer therapyJens Ulrich, Jörg T Hartmann, Wolfgang Dörr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 2019
[Merkel cell carcinoma]Christina Drusio, Jürgen C Becker, Dirk Schadendorf, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2004
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?Selma Ugurel, Monika Lindemann, Dirk Schadendorf, et al.
Current Opinion in Oncology|January 22, 2013
New developments in biomarkers for melanomaKlaus G Griewank, Selma Ugurel, Dirk Schadendorf, et al.
American Journal of Clinical Dermatology|April 22, 2024
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic UpdatesJürgen C Becker, Andreas Stang, David Schrama, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Merkel cell carcinoma immunotherapy: key questions in the era of immune checkpoint blockadeJürgen C Becker, Georg Lodde, Maximilian Haist, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 28, 2019
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Imatinib in melanoma: a selective treatment option based on KIT mutation status?Jürgen C Becker, Eva B Bröcker, Dirk Schadendorf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 15, 2005
[90-year-old male with a hyperkeratotic lichenoid skin eruption]Ute Bauer, Selma Ugurel, Jochen Utikal, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 25, 2011
Regression of paclitaxel-induced maculopathy with oral acetazolamideKerstin Maria Meyer, Thomas Klink, Selma Ugurel, et al.
Pageof 27